search
Back to results

Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease (PREDICT)

Primary Purpose

Crohn Disease

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
blood sample
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Crohn Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged over 18 years
  • Men or non-pregnant women
  • Patients with a diagnosis of Crohn's disease who undergo an ileo-colonic curative resection
  • No change of the postoperative treatment before assessing an endoscopic recurrence during the one-year post surgery follow-up period
  • Informed consent given

Exclusion Criteria:

  • Pregnancy
  • History of disease, including mental/emotional disorder, that might interfere with their participation in the study
  • Inability to comply with the protocol requirements
  • Inability to fill in the diary cards

Sites / Locations

  • Service d'Hépato-Gastroentérologie Centre hospitalier Lyon Sud Hospices Civils de Lyon

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Postoperative endoscopic recurrence

Arm Description

Patients with a diagnosis of Crohn's disease who undergo an ileo-colonic curative resection

Outcomes

Primary Outcome Measures

Postoperative endoscopic recurrence, assessed by a Rutgeerts 's score > i1, over the one-year post-surgery follow-up
Rutgeerts 's score > i1

Secondary Outcome Measures

proportion of T cell subsets in the arm of patients who will experience a recurrence and those who will not.
number of T cell subsets in the arm of patients who will experience a recurrence and those who will not.

Full Information

First Posted
May 9, 2016
Last Updated
May 10, 2016
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT02770495
Brief Title
Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease
Acronym
PREDICT
Official Title
Dynamics of Regulatory and Effector T Lymphocyte Subsets in Patients With Crohn's Disease During Postoperative Recurrence : Implications for Identifying Patients at High Risk of Relapse.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2016
Overall Recruitment Status
Completed
Study Start Date
January 2011 (undefined)
Primary Completion Date
April 2016 (Actual)
Study Completion Date
April 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
It is assumed that gut inflammation and lesions characterizing flares of Crohn's disease (CD) result from an aberrant T-cell mediated immune responses characterized by a complex balance between peripheral and lamina propria regulatory and effector T cell subsets. Because most of CD patients who undergo a surgery experienced a postoperative endoscopic recurrence of the disease (70 % at one year) leading to a clinical recurrence (10 % per year), the "model" of postoperative recurrence in CD represents a privileged situation that mimicks what happens in the gut of CD patients in clinical remission before the occurrence of further flares. It is likely that the same factors which underlie the immunopathogenesis of CD at its early stages also contribute to disease recurrence in the postoperative setting. Indeed, the postoperative state is performed for intent of disease remission and this situation represents probably an ideal setting to investigate the dynamics of most of T cell subsets in the peripheral and mucosal compartments because one may argue that removal of the diseased segment of bowel resets the disease to its earliest phases, providing an interesting window to better understand which T cell subsets predispose to disease recurrence. That is the reason why this model will be used in the present project i) to understand better the immunopathogenesis of CD relapse; ii) to identify novel and promising immune cell-associated biomarkers capable to predict relapse of the disease and finally iii) to identify potential specific therapeutic target associated with T cell subsets involved in the initiation of disease.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Crohn Disease

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
59 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Postoperative endoscopic recurrence
Arm Type
Experimental
Arm Description
Patients with a diagnosis of Crohn's disease who undergo an ileo-colonic curative resection
Intervention Type
Other
Intervention Name(s)
blood sample
Primary Outcome Measure Information:
Title
Postoperative endoscopic recurrence, assessed by a Rutgeerts 's score > i1, over the one-year post-surgery follow-up
Description
Rutgeerts 's score > i1
Time Frame
at one year
Secondary Outcome Measure Information:
Title
proportion of T cell subsets in the arm of patients who will experience a recurrence and those who will not.
Time Frame
at 3 months before relapse
Title
number of T cell subsets in the arm of patients who will experience a recurrence and those who will not.
Time Frame
at 3 months before relapse

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged over 18 years Men or non-pregnant women Patients with a diagnosis of Crohn's disease who undergo an ileo-colonic curative resection No change of the postoperative treatment before assessing an endoscopic recurrence during the one-year post surgery follow-up period Informed consent given Exclusion Criteria: Pregnancy History of disease, including mental/emotional disorder, that might interfere with their participation in the study Inability to comply with the protocol requirements Inability to fill in the diary cards
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stéphane NANCEY, MD
Organizational Affiliation
Service d'Hépato-Gastroentérologie Centre hospitalier Lyon Sud Hospices Civils de Lyon
Official's Role
Principal Investigator
Facility Information:
Facility Name
Service d'Hépato-Gastroentérologie Centre hospitalier Lyon Sud Hospices Civils de Lyon
City
Pierre Benite
Country
France

12. IPD Sharing Statement

Learn more about this trial

Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease

We'll reach out to this number within 24 hrs